Most laboratory strains of mice have between two and eight endogenous superantigens. These viral superantigens (vSAGs) are coded by genes in the 3' long terminal repeats of endogenous mammary tumor viruses (Mtv's). A line of Mtv-negative mice and several lines of mice containing single Mtv's were created by inbreeding the F2 progeny of CBA/CaJ and C58/J mice, which have no Mtv integrants in common. This allowed the T cell repertoire of H-2 k mice, unaffected by Mtv superantigens, as well as the effects of vSAGs upon that repertoire, to be studied. Although each individual mouse had a different mix of C58/J and CBA/CaJ background genes, the T cell repertoires of different Mtv-negative mice were very similar and were reproducible. Since the background genes did not affect the V[3 repertoire, there are no superantigens, other than those encoded by Mtv's, that differ between CBA/CaJ and C58/J. CD4 and CD8 T cells had quite different repertoires in the Mtv-negafive mice because of the effects of class I and class II major histocompatibility complex molecules on positive and negative selection, vSAG3 was found to delete V[35 T cells, while vSAG8 deleted V[37 T cells, and vSAG9 deleted V[313 T cells in addition to their previously reported specificities, vSAG17 deletes a small proportion ofCD4 + T cells bearing V[311 and -12. vSAG14 and -30 have httle effect on the T cell repertoire and are not expressed in thymocytes and splenocytes. An endogenous superantigen that has a low avidity for a particular V[3 may positively select thymocytes, leading to an increased frequency of peripheral T cells bearing the relevant V[3s. We found evidence that vSAG11 may positively select T cells bearing V[38.2. Our data, which analyzed the effects of seven endogenous Mtv's, showed little evidence of positive selection by any other vSAGs on T cells bearing any V[3 tested, despite published reports to the contrary.
M
ls gene products can stimulate T cells (1) because of .the ability of the superantigens encoded by Mls-like genes to stimulate and/or delete T cells bearing certain V[3 chains in their cx/[3 TCRs (2, 3) . The known viral superantigens (vSAGs) 1 in mice are encoded in the 3' LTR of mammary tumor viruses (MTVs) (4) (5) (6) (7) . These MTVs exist both as replicating virions, passed from mother to pup in the milk, and as endogenous chromosomal integrants, which are inherited genetically. There are at least 30 known endogenous MTVs, distributed among the various mouse strains and wild mice.
1Abbreviations used in this paper: MTV, mammary tumor virus; RT, reverse transcfiptase; vSAG, viral superantigen.
The specificities of these vSAGs have been demonstrated by their ability to stimulate T cells or by their ability to delete T cells bearing certain V[3s in mouse strains containing the superantigen genes compared with strains that do not. The difficulty with this analysis has been that almost all presenting cells and mouse strains contain several Mtv integrants, and the effects of particular superantigens cannot be unambiguously separated from those of other superantigens present in the same cell line or mouse. In addition, the effects of the H-2 haplotype on the T cell repertoire and on the vSAGs make interpretation of differences difficult.
To circumvent these problems, a line of mice was created that was free of Mtv's. Although two strains of mice free of Mtv's have been previously described, neither contained a well-known MHC haplotype (8, 9) . Simulta-neously, mouse lines carrying the same MHC genes (H-2 k) and single Mtv integrants were produced. This was accomplished by crossing two strains of H-2~expressing mice that do not have any Mtv integrants in common, CBA/CaJ and C58/J, and selectively breeding their progeny. These studies allowed an assessment of the T cell V[3 repertoire in the absence of vSAGs and a search for superantigenlike proteins other than vSAGs that differ between the two strains.
Comparison of the single-Mtv mouse lines with the Mtvnegative lines allowed the evaluation of the effects of each vSAG on positive and negative selection. In general, only thymocytes that recognize antigen in the context of the MHC molecules found in the thymic epithelia are positively selected for maturation, survival, and export to the periphery (10) (11) (12) (13) . However, developing thymocytes that recognize self-antigens bound to MHC molecules are eliminated by a process called negative selection (2, 3, (14) (15) (16) (17) (18) . The "thymic paradox" is that thymocytes must recognize self-MHC to survive but are eliminated if they recognize self-MHC plus self-peptide. The avidity hypothesis explains this paradox by stating that thymocytes with a low but perceptible avidity for self-peptide/MHC are positively selected, while thymocytes with a higher avidity for selfpeptide/MHC are deleted (19, 20) . Recent experiments using fetal thymus organ culture support this hypothesis (21) (22) (23) . If the avidity hypothesis is correct, a vSAG expressed in the thymic epithelium that had a very low avidity for a particular TCR V[3 element would allow T cells bearing that V[3 element to be positively selected, and the frequency of peripheral T cells bearing that V]3 element would increase. When we compared the V~ frequencies of eight single-Mtv mice with those of Mtv-negative mice, we found evidence of such positive selection by only one vSAG.
Materials and Methods
Mice. C58/J, CBA/CaJ, AKR/J, and C57BL/6J mice were obtained from The Jackson Laboratory (Bar Harbor, ME). Crosses between mice were performed in the National Jewish Center animal care facility (Denver, CO).
Southern Blots. Genomic DNA was prepared from mouse tails by proteinase K digestion (0.8 mg/ml in 5% SDS, pH 7.5) and was digested with either NcoI or BstXI, subjected to electrophoresis on 0.75% agarose gels, and transferred to nylon filters (Genescreen; DuPont, Wilmington, DE) using blotting apparatus (VacuGene XL; Pharmacia Biotech, Inc., Piscataway, NJ). The filters were probed with an EcoRI-BamHI fragment of the MTV(C3H) LTR cloned into pTZ18R-orfl (24) . The probe was labeled with 32p by random priming (Random Primers Kit; GIBCO BRL, Gaithersburg, MD), and hybridized at 65~ in 500 mM phosphate buffer, pH 7.2, 7% SDS. The filters received two final washes with 1% SDS, 40 mM phosphate buffer, and were exposed for 1-7 d on x=ray film (XR; Eastman Kodak Co., Rochester, NY). The PCR product was cut with EcoRl and BamHl. The 1-kb band was size separated and purified by agarose gel electrophoresis and GeneClean, and then cloned into PTZ 18R and sequenced by the chain termination method (36) using Sequenase (United States Biochemical Corp., Cleveland, OH).
Reverse Transaiptase (RT)-PCR.
RNA was prepared from splenocytes and thymocytes by lysis and precipitation in 3 M LiC1/6 M urea. The RNA was then resuspended in 10 mM Tris, pH 8.0, 5 mM EDTA, 1% SDS, and was phenol/chloroform, and then chloroform extracted, followed by ethanol precipitation. Residual DNA was digested by incubating for 10 rain at 37~ with 5 U of RNase-free DNase I (Boehringer Mannheim Corp., Indianapolis, IN), followed by phenol/chloroform extraction, cDNA was made from 2 p,g of total RNA using the superscript RT and random hexarners (GIBCO BRL). vsag transcripts were amplified by 35 cycles of PCR (95~ for I rain, 55~ for I rain, 72~ for 1 rain) using pan-vsag-specific primers. The 5' primer was GGG-AATTCTCGAGATGCCGCGCCTGCAG, and the 3' primer was ACACCAAGGAGGTCTAGC.
Statistics.
All results are shown as the average value of all the mice tested + SEM. The deletion significance levels (P) were calculated using the one-tailed Student's t test. After correcting the nondeleted V[5 frequencies for the deletions (see below), a twotailed t test was used to determine the significance of any further positive or negative V~ skewing. A P value <0.003 was required for significance, since 16 tests were performed on each mouse line (5% + 16 = 0.003).
Frequency Conrction for T Cells Bearing Nondeleted V~s.
To normalize the frequency of T cells bearing undeleted V~s, these fre= quencies must be multiplied by the ratio of the frequency of T cells bearing these V~s in Mtv-negative mice/the frequency of T cells bearing these V~s in a single-Mtv mouse line. Since V~I, -15, and -16 could not be directly measured, two separate methods of normalization were used. The first method included the estimated frequency of V~I, -15, and -16 by subtracting the frequencies of measured V[Ss from 100%. However, if there was ev= idence of deletion among VI31, -15, or -16, then a second calcu-lation was used, which normalized only those Vl3s that were directly measured and not deleted. For example, in Mtv8 mice, V135.1, -5.2, -7, and -11 and 12 CD4 + T cells are deleted and account for 6.0% ofCD4 + T cells, while they account for 23.9% of CD4 + T cells in Mtv-negative mice. By the first method, the correction factor is (100 -23.9)/(100 -6.0) = 0.810. However, after correcting, it is clear that at least one of the untested VI3 is being deleted. Therefore, these VI3s are not used in the second method, and the correction factor adds the frequencies of T cells beating the undeleted V~2, -3, -4, -6, -8.1, -8.2, -8.3, -9, -10, -13, and-14 = (53.4/73.4) = 0.728. (38) . Two back-cross experiments were conducted to verify the existence of two distinct integration sites, using CBA/CaJ mice that do not contain The Sequence ofvSAG30. Genomic DNA from AKR/ J, C57BL/6J, and RF/J mice was digested with EcoRI and separated by agarose gel electrophoresis. DNA from the 12-30-kb region, where Mtv30 is found, was cut out, isolated, and amplified by PCR using pan-vSAG-specific 5' and 3' primers. PCR products were cloned into pTZ (35) . Clones from all of the mice had the same sequence ( Fig. 1) , even though AKR/J and C57BL/6J mice have two distinct
Results

CBA/CaJ mice contain
Mtv30 proviruses with unlinked integration sites. The amino acid sequence of vSAG30 is most closely related to that ofvSAG9 ( Fig. 1) , from which it differs by 14 residues. Perhaps surprisingly, most of these differences are not clustered at the carboxy-terminal end of the protein, the portion thought to confer VI3 specificity. If expressed, vSAG30 might therefore share the specificities of vSAG9 for T cells bearing V135.1, -5.2, -11, and -12. vsag RNA from mice containing vsag3, -7, and -17 was expressed in the spleen and thymus (Fig. 4) . vsag P, NA was found in the spleen, but not in thymocytes of mice containing vsag8 and -9. Even so, however, vsag8 and -9 might be expressed in the thymic epithelium or in cell types less frequent in the thymus, such as macrophages, Table 3 ).
Generation of the Mtv-negative and Single-Mtv Mouse Lines.
These previously uncharacterized superantigens had only small effects on the T cell repertoire. Only VI3 frequency differences with a P value "<0.003 by the Student's t test are discussed.
Mtv14 mice had a slight reduction in the frequency of V132 CD4 but not CD8 T cells by comparison with Mtvnegative animals. The sequence of vSAG14 has not been determined but may be similar to the exogenous MTVs previously reported to react with T cells bearing VI32 (39) (40) (41) .
vSAG30 is very similar in amino acid sequence to vSAG9 ( Fig. 1 ) and should therefore delete the same subset of T cells as vSAG9, i.e., those bearing V135.1, -5.2, -11, and -12. However, vsag30 is not expressed or is only poorly 1 
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ATGCcGCG~CTGCAGCAGAAATGG-rTG~ACT~C~GT~CTACACTTAGGA~CAAG~G~TTG-n-~C~CA~CAAGGACGA~Cc~C~T~C~ Mtv9 cells bearing these VI3s and none of the other V[3s tested ( Fig. 7 and Table 3 ), The efficiency of deletion of the various VI3s confirms the hypothesis that vSAG7 has the strongest avidity for V136, followed by VI38.1 and VI39, and then V[37 (45) .
vSAG3, a member of the Mtvl, -3, -6, and -13 family of viral superantigens, has been reported to delete T cells bearing V133, and this is borne out in our mice ( Fig. 7 and Table 3 ). However, vSAG3 also reacts with CD4 and CD8 T cells bearing V[35.1 and -5.2, since many of these cells disappeared in Mtv3 mice. This is a novel finding but not entirely unexpected, as vSAG6, a closely related protein, was previously reported to delete VI35-bearing T cells (46) . Since the carboxy-terminal 60 amino acids ofvSAG1, -3, -6, and -13 are almost identical, we would expect that vSAG1 and vSAG13 would also induce deletion o f T cells bearing V135.1 and VI35.2. vSAG3 also induced deletion of about one-fourth of the CD4 T cells bearing the Vl3s not tested (Vl3sl, -15, and -16).
Mtv8, -9, and -11 have related sequences, vSAG8, vSAG9, and vSAGll all induce deletion of CD4 T cells bearing V135.1, -5.2, -11, and -12, although vSAG9 induces the most complete deletion (Fig. 8 and Table 3 ). However, the efficiencies of deletion of CD8 T cells differ greatly between the three superantigens, probably because of better expression of vSAG9 rather than sequence differences between the superantigens, vSAG9 deletes most of the CD8 T cells bearing V[~5.1, -5.2, -11, and -12; vSAG11 deletes V[35.2-, V[311-, and V[312-bearing CD8 T ceils; while vSAG8 deletes only V[312-bearing CD8 T cells. The specificities ofvSAG8, -9, and -11 had some minor differences with those previously reported (47) . In the previous paper, vSAG8 and -11 were thought not to delete V[35-bearing T cells. This conclusion was probably reached because CD4 and CD8 T cells were not measured separately, and vSAG8 and -11 do not delete CD8 V[~5 T cells eflqciently. Since V~5 T cells are overrepresented in the CD8 population compared with the CD4 population, detection of the CD4 deletion might be hindered when total T ceils are compared.
Interestingly, vSAG8 also deletes CD4 T cells bearing V[37 ( Fig. 8 and Table 3 ), while vSAG9 and -11 do not. This might be because of minor amino acid differences between vSAG8 and -9 (see Discussion). In addition, vSAG9 deletes about one-fourth of CD4 T cells bearing V[313.
Positive Selection by Mtv vSA Gs. vSAGs are noted for their ability to induce deletion in the thymus of T cells bearing particular V[3 chains. However, they might also participate in positive selection. Fig. 10 and Table 3 ). This could be because of positive selection. The increased frequency of V[38.2 CD4 T cells was observed in two separate experiments. There were no other significant increases in V[3 frequency after correction for the deletions.
The corrected frequencies also allowed a more careful study of weak VI3-specific deletions. If only a small proportion of T cells bearing a particular V[$ are deleted (perhaps because of the ci or the D-or J[3), the remaining T cells bearing that VI3 will increase in frequency because of other deletions, masking the small deletion that takes place. This actually occurs with several vSAGs.
Mtv7 and Mtv-negative mice have identical frequencies of V[38.2 CD4 T cells, and Mtv7 mice actually have a higher frequency ofV[38.2 CD8 T cells (Fig. 7) . However, after correction for the other deletions caused by vSAG7, the frequency of V[38.2-bearing T cells is reduced by 13% in Mtv7-expressing mice ( Fig. 9 and Table 3 ). This confirms earlier studies showing that vSAG7 could stimulate some but not most V~8.2 T cell hybridomas (2, 48) . Similarly, after correction, Mtv9 and Mtv 11 mice have reduced frequencies ofCD8 T cells bearing V[~13, while Mtv8 mice have reduced frequencies of CD4 T ceils bearing V[313. 
Discussion
Mtv30 Duplication and Sequence. W e have shown that there are two unlinked Mtv30 bands in C58/J mice and that the Mtv's known as 30 are at different chromosomal locations in A K R / J and C57BL/6J mice. Therefore, it is probable that C58/J mice contain both the integrant found in AKtk/J and the integrant in C57BL/6J. Since the two integrants are unlinked, it should be possible to separate them on a Southern blot using an appropriate restriction enzyme. However, we could not separate the two Mtv30 integrants using six enzymes: EcoRI, PvulI, NcoI, BstXI, ScaI, or BsmI, even though ScaI and BsmI cut within the Mtv30 L T R (data not shown). This could be explained if the predecessor virus of Mtv30 integrated in a region o f a chromosome that was subsequently duplicated. If the flanking regions were also duplicated, the size o f the bands containing the L T R would always be the same.
The sequence of vSAG30 is very similar to that of other members of the M/sf family, vSAG8, -9, and -11. Thus, we would expect it to have the specificity characteristic of this family for T cells beating V [35, -11, and -12. However, vSAG30 does not induce any deletions, probably because of poor or no expression, which could result from a defect in the promoter. Another hypothesis is that the whole chromosomal region where Mtv30 integrated has been shut off, e.g., by excess methylation or centromeric proximity. If it is a region of chromosomal duplication, this might prevent deleterious effects of increased gene dosage to the mouse.
Specificity of vSA G8, -9, and -11. The M/sf family, which includes Mtu8, -9, and -11, has a previously reported specificity for T cells bearing V~5.1, -5.2, -11, -12, and -17a. Our results show that they also have a weak reactivity with T cells bearing V~13 and at least one other V~ among V~I, -15, and -16. This is probably V~16, as it is quite homologous to V[311 and -12. Mtu17 also belongs in this family by virtue of its specificity for T cells bearing VJ~I 1, and -12. However, the published sequence of vSAGt7 is slightly different from vSAG8, -9, and -11 (42, 49) and homologous to vSAG23, which is specific for VJ37 (35) . Although vSAG23 only stimulated T cell hybrids bearing VI37 (35) , it is possible that it induces the deletion o f T cells Why vSAG8 Deletes V~7-bearing T Cells. vSAG8 deletes T cells bearing V[37, while superantigens encoded by other members of the MI.4 family, Mtv9 and Mtv 11, do not. The only sequence difference in the carboxy-terminal polymorphic region of these three superantigens is that vSAG8 has an isoleucine rather than a methionine at position 273. vSAGs contain a second polymorphic region at residues 174-198, which was shown not be involved in vSAG7 and vSAG1 specificities for V[38.1 and V~33, respectively (50) . It is noteworthy, however, that the V[37-reacting vSAGs: vSAG8, vSAG23, vSAG(M12), and vSAG(SHN), all contain a glutamic acid at residue 176, an arginine at residue 183, and a leucine at residue 197 (35, 51) . It is our hypothesis that the first polymorphic region between residues 174 and 198 contributes to specificity for V[37, while the specificity for other V[3s may be determined solely by the carboxy-terminal residues. The first polymorphic region may have a purely negative contribution to binding, with cer- rain residues sterically hindering the association with VI37. vSAG7 and other members of the Mls-1 family also react with V[37. However, since their sequence at both polymorphic regions is completely different from those of the vSAGs discussed here, they probably bind VI37 in a different way, such that their V[37 specificity is inseparable from that for V [36, -8.1, and -9. Positive Selection by vSAGs. Positive selection can be defined as the process that selects for survival T cells that bear an avidity for self-MHC and foreign peptide. However, the thymocytes actually selected are only exposed to self-MHC/self-peptide during the event. The avidity hypothesis states that T cells with a low avidity for self-MHC/selfpeptide are positively selected, and that these T cells will cross-react with a high avidity for self-MHC and some foreign peptide. If the avidity hypothesis of positive selection is correct, vSAGs might cause the overselection of T cells bearing V[3s with which the vSAGs could react weakly. While there have been reports of possible positive selection by vSAGs (52), others have not found any evidence of it (53) (54) (55) (56) . However, any positive selection present in these systems could have been obscured by positive selective effects that are ubiquitous to all Mtv vSAGs or by the deletions also occurring in most mice.
We could examine the frequency of 16 different V[3s in the mice used in these experiments with a wide range of similarities to one another. For example, the amino acid residues ofV[312 are 68% identical to those of V~311, 23% identical to V[32, and intermediately identical to several other V[3s. We expected that at least one of these V[3s would have a low enough avidity for the vSAGs which recognize VJ312 well to be positively selected. We found that V~38.2 CD4 T cells seemed to be positively selected by vSAG11, vSAG8 also led to an increase in Vl38.2 CD4 T cells, that was not significant after correction (P = 0.11). Therefore, we feel that vSAG8 may also slightly positively select VI38.2 T cells, but that this selection is masked by our inability to correct for V[31 and VJ315, since no antibody against these V[3s is yet available. Vl38.2 is the VI3 most homologous to V[37 (62% amino acid homology). Since vSAG8 has a high enough avidity for VJ37 to induce deletion, it may have a lower avidity for V[38.2. Similarly, vSAG11, which does not delete V[37, may have an even lower avidity for V[38.2, an avidity in the right range for positive selection to occur.
Our results indicate that vSAG7 does not positively select CD4 VI314 T cells (P = 0.08) or CD8 V~314 T cells (P = 0.16), an observation which contradicts previous findings that vSAG7 positively selected Vj314-bearing T cells in several strains of mice, including some that shared the MHC haplotype (H-2 k) used in our experiments (52) . The most probable explanation for the disparity is that the increased selection was due to strain-specific effects. Another possible explanation for the difference is that several vSAGs somehow cooperate to produce specificities that are not present in the individual vSAGs.
Although eight vSAGs were investigated for effects on 15 different V[3s, only one increase of V[3 usage was seen that could be due to positive selection, and the affected V~3 frequency rose by only 10%, after correcting for the other deletions. Several theories can be put forward to explain the paucity of observed positive selection by the vSAGs.
The most interesting would be that thymocytes require another signal in addition to low-avidity binding of their TCR to be positively selected. For example, ifa conformational change in the TCR. is required for activation (57) , this change may preclude positive selection. If vSAGs always induce the conformational change, they would be incapable of inducing positive selection.
A simpler explanation is that few of the other Vj3s are homologous at the vSAG-binding site, even though there is much overall sequence homology. Since the vSAGbinding site is not yet known, this cannot be disproved. Similarly, most V[3s that bind with sufficient avidity to be positively selected may subsequently be negatively selected. This seems unlikely because of the large number of homologous V]3s and vSAGs, some of which should have interactions of low enough avidity to avoid deletion in the thymus. However, a low-avidity interaction between vSAG and V[3 might be influenced by D [3, J[3, or Vs. In this case, the vSAG might positively select some T cells bearing a particular V[3 while having a high enough avidity to delete other T cells bearing the same V~. In such a case, there could be an increase, decrease, or no change in the V[3 frequency. Again, it seems unlikely that the frequencies of aI1 V~s would remain unchanged.
Some aspect of positive selection may preclude most vSAGs from selecting. An interesting possibility is that the vSAG-binding site on VJ3 TCR is occupied by another molecule during positive selection. This hypothetical molecule, possibly a cellular SAG structurally related to superantigens, could be an avidity enhancer molecule present only in positively selecting cells (58) or present in all TCR-MHC interactions (59) . The binding of this molecule would block only low-avidity interactions of the vSAG to nonoptimal V[3s but not the bigb-avidity interaction with the deleted Vl3s. Finally, ira particular ceil type such as cortical epithelial cells were responsible for positive selection in the thymus in vivo, the positively selecting cell might not express the vSAGs.
